Curetis OpGen Q1 Revenues Rise 34 Percent on Combination With Curetis OpGen said it is awaiting a clearance decision for its Unyvero pneumonia cartridge in China, where it is currently under review and pending approval. OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval The company's cartridge for pneumonia for the Unyvero system is under review and pending approval by Chinese regulators. OpGen Posts 70 Percent Increase in Q3 Revenues Amid Shuffling of Portfolio The firm beat the consensus Wall Street estimate on the top line but fell short of the estimate on the bottom line. Multiplex PCR Panels for Joint Infections on the Horizon Premium BioFire has submitted a 39-target test to the US Food and Drug Administration. OpGen also has a test in development. OpGen Posts 54 Percent Increase in Preliminary Q3 Revenues, Consolidates Product Portfolio Following its recent acquisition of Curetis, OpGen has also shifted its focus onto its Unyvero molecular diagnostics platform and bioinformatics operations. Sep 30, 2020 Curetis Receives €350K German Government Grant to Develop Carbapenem Resistance Test Aug 20, 2020 OpGen Nabs CE-IVD Mark for SARS-CoV-2 Kit Aug 12, 2020 OpGen Q2 Revenues Climb 20 Percent Jul 9, 2020 Curetis Gains Access to Additional €5 Million Debt Financing for COVID-19 R&D May 7, 2020 OpGen Q1 Revenues Drop 38 Percent Apr 21, 2020 Curetis, Karolinska Institute Collaborate to Identify Bacterial Co-Infections in COVID-19 Patients Apr 14, 2020 OpGen Q1 Preliminary Revenues Down 38 Percent Mar 24, 2020 OpGen Fourth Quarter Revenues Increase 8 Percent Feb 20, 2020 Curetis Preliminary 2019 Revenues Up 64 Percent Feb 12, 2020 OpGen Preliminary 2019 Revenues up 19 Percent Feb 6, 2020 Curetis Signs Vietnam Distribution Deal for Unyvero Dx System, Cartridges Jan 30, 2020 Ares Genetics Collaborates With BGI on Coronavirus Testing in Europe Dec 20, 2019 FDA Clears Curetis Lower Respiratory Tract Infections Panel Nov 25, 2019 Curetis Reports 17 Percent Revenue Increase for First Nine Months of 2019 Nov 14, 2019 Curetis Posts 17 Percent Increase in Preliminary Revenues for First Nine Months of 2019 Nov 6, 2019 OpGen Posts 17 Percent Increase in Q3 Revenues Oct 24, 2019 OpGen Prices $9.4M Stock, Warrant Offering Oct 15, 2019 OpGen Plans $10.4M Stock, Warrant Sale Sep 18, 2019 Curetis Reports 36 Percent Increase in H1 Revenues Sep 4, 2019 OpGen, Curetis Enter Merger Agreement Load More Breaking News Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More FDA Grants Emergency Use Authorization for Northeastern University SARS-CoV-2 Test The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.